Kukushkin S K, Vygodin V A, Kokurina E V, Metelitsa V I, Bochkareva E V
Kardiologiia. 1993;33(5):18-21.
The paper shows methodological approaches to assessing the interaction (antagonism and synergism) of antianginal agents in their combination used in 15 patients with stable angina. Each patient underwent paired bicycle ergometry with placebo, isosorbide dinitrate, 10 mg (ID), nifedipine, 20 mg (N), propranolol, 40 mg (P), and a combination of the drugs: ID, 10 mg, +P, 40 mg; N, 20 mg, +P, 40 mg; ID, 10 mg+N, 20 mg. The results were processed by two-dimensional dispersion analysis. Based on the findings, it was concluded that the interaction of drugs in all combinations was statistically insignificant in patients. At the same time the developed individual criteria for assessing the interaction allowed patients both with synergic and antagonistic interaction of antianginal drugs to be revealed.
该论文展示了评估抗心绞痛药物联合使用时相互作用(拮抗和协同)的方法,研究对象为15例稳定型心绞痛患者。每位患者均接受了以下配对运动试验:服用安慰剂、10毫克硝酸异山梨酯(ID)、20毫克硝苯地平(N)、40毫克普萘洛尔(P),以及药物组合:10毫克ID + 40毫克P;20毫克N + 40毫克P;10毫克ID + 20毫克N。结果采用二维离散分析进行处理。基于这些发现得出结论,在患者中所有组合的药物相互作用在统计学上均无显著意义。同时,所制定的评估相互作用的个体标准能够识别出抗心绞痛药物具有协同和拮抗相互作用的患者。